The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1264
ISSUE1264
July 2, 2007
Resperate for Hypertension
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Resperate for Hypertension
July 2, 2007 (Issue: 1264)
The FDA has approved the marketing of Resperate (InterCure), a device that helps patients breathe slowly, as an adjunct for treatment of hypertension. The FDA does not require proof of effectiveness for approval of devices with minimal potential for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.